Captopril administration reduces thrombus formation and surface expression of platelet glycoprotein IIb/IIIa in early postmyocardial infarction stage

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1791-1795

  Zurbano, María J ^a   Anguera, Ignasi ^a   Heras, Magda ^a   Roig, Eulàlia ^a   Lozano, Miguel ^a   Sanz, Ginés ^a   Escolar, Ginés ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Captopril; Flow cytometry; Platelets; Vessel wall

Indexed keywords

ACETYLSALICYLIC ACID; CAPTOPRIL; FIBRINOGEN RECEPTOR; TICLOPIDINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; IMPENDING HEART INFARCTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION INHIBITION; THROMBUS;

EID: 0033032519     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1791     Document Type: Article

References (37)

1. The SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-677.
2. The Acute Infarction Ramipril Efficacy (AIRE) study investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
3. Ventura HO, Frohlich ED, Messerli FH, Kobrin I, Kardon MB. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension. Am J Cardiol. 1985;55:1023-1026.
4. Remme WJ. Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy? Drugs. 1997;54(suppl 5):59-70.
5. Hutri-Kahonen N, Kahonen M, Tolvanen JP, Wu X, Sallinen K, Porsti I. Ramipril therapy improves arterial dilation in experimental hypertension. Cardiovasc Res. 1997;33:188-195.
6. Henrion D, Dechaux, E, Dowell FJ, Maclour J, Samuel JL, Levy BI, Michel JB. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. Br J Pharmacol. 1997;121:83-90.
7. Vaughan DE. The renin-angiotensin system and fibrinolysis. Am J Cardiol 1997;79:12-16.
8. Oshima S, Ogawa H, Mizuno Y, Yamashita S, Noda K, Saito T, Sumida H, Suefuji H, Kaikita K, Soejima H, Yasue H. The effects of angiotensin-converting enzyme inhibitor imidapril on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction. Am Heart J. 1997;134:961-966.
9. HEART Study Investigators. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation. 1997;96:442-447.
10. Keidar S, Oiknine J, Leiba A, Shapira C, Liba M, Aviram M. Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients. J Cardiovasc Pharmacol. 1996;27:183-186.
11. Moser L, Callahan KS, Cheung AK, Stoddard GJ, Munger MA. ACE inhibitors effects on platelet function in stages I-II hypertension. J Cardiovasc Pharmacol. 1997;30:461-467.
12. Gavras H, Kremer D, Brown JJ. Angiotensin and norepinephrine induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J. 1974;89:321-332.
13. Born GVR. The aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927-929.
14. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res. 1973;5:167-179.
15. Turitto VT, Baumgartner HR. Platelet-surface interactions. In: Colman RW, Hirsh J, Marder VJ, Salzmann EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: Lippincott: 1982.
16. Escolar G, Bastida E, Castillo R, Ordinas A. Development of a computer program to analyze the parameters of platelet-vessel wall interaction. Haemostasis. 1986;16:8-14.
17. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;70:307-315.
18. Scharf RE, Tomer A, Marzec UM, Teirsten PS, Ruggeri ZM, Harker LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries flow cytometric detection. Arterioscler Thromb. 1992; 12:1475-1487.
19. Escolar G, Bastida E, Ordinas A, Castillo R. Interaction of platelets with subendothelium in humans treated with aspirin and dipyridamole alone or in combination. Thromb Res. 1985;40:419-424.
20. Steffensen R, Grande P, Madsen JK, Rasmussen S, Haunso S. Short-term effects of captopril on exercise tolerance in patients with chronic stable angina pectoris and normal left ventricular function. Cardiology. 1995; 86:445-450.
21. Rector TS. Effect of ACE inhibitors on the quality of life of patients with heart failure. Coron Artery Dis. 1995;6:310-314.
22. Trandolapril Cardiac Evaluation (TRACE) study group. A clinical trial of the angiotensin-converting enzyme-inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1995;333:1670-1676.
23. Aspirin Myocardial Infarction Study Research Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA. 1980;243:661-669.
24. Hennekens CH, Buring JE, Sandercock P, Collins R, Peto R. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation. 1989;80:749-756.
25. Baumgartner HR, Muggli R. Adhesion and aggregation: morphological demonstration and quantitation in vivo and in vitro. In: Gordon JL, ed. Platelets in Biology and Pathology. Amsterdam: Biomedical Press; 1976.
26. Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A. Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion. 1988;28:406-411.
27. Meyer D, Baumgartner HR. Role of von Willebrand factor in platelet adhesion to the subendothelium. Br J Haematol. 1983;54:1-9.
28. Nievelstein PFEM, de Groot PG, Dalessio P, Heijnen HFG, Orlando E, Sixma JJ. Platelet adhesion to vascular cells. The role of exogenous von Willebrand factor in platelet adhesion. Arteriosclerosis. 1990;10:462-469.
29. Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb/IIIa, Ib, and storage granules. Blood. 1986;67:322-330.
30. van Zanten GH, Heijnen HF, Wu Y, Schut Hese KM, Slootweg PJ, de Groot PG, Sixma JJ, Nieuwland R. A fifty percent reduction of platelet surface glycoprotein Ib does not affect platelet adhesion under flow conditions. Blood. 1998;91:2353-2359.
31. Nishimura H, Tsuji H, Masuda H, Nakagawa K, Nakahara Y. Kitamura H, Kasahara T, Sugano T, Yoshizumi M, Sawada S, Nakagawa M. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells. Thromb Haemost. 1997;77:1189-1195.
32. Weiss H, Turitto V, Baumgartner H, Nemerson Y, Hoffmann T. Evidence for the presence of tissue factor activity on subendothelium. Blood. 1989;73:968-975.
33. Dejana E, Cazenave JP, Hatton MW, Richardson M, Groves HM, Kinlough Rathbone RL, Packham MA, Mustard JF. The effect of thrombin on platelet accumulation on the vessel wall: influence of heparin and aspirin. Thromb Haemost. 1983;50:567-571.
34. Boadle MC, Hughes J, Roth RH. Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues. Nature. 1969;222: 987-988.
35. Salathe M, Weiss P, Ritz R. Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. Br Heart J. 1992;68:527-528.
36. Rao GH, White JG. Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am J Hematol. 1981; 11:355-366.
37. Rao GH, Escolar G, White JG. Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res. 1986;44:65-74.